Jan 30 |
NovaBay Pharmaceuticals posts 64% rise in 2023 Avenova unit subscription-based sales
|
Jan 30 |
NovaBay Pharmaceuticals Reports 64% Year-Over-Year Growth in Avenova Unit Subscription-Based Sales
|
Jan 29 |
Why ZIM Integrated Shipping Services Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
|
Jan 9 |
NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma’s Extensive Distributor Network
|
Dec 6 |
NovaBay Pharmaceuticals Partners with Woo University to Educate Eyecare Professionals on the Use of Amniotic Membranes
|
Nov 12 |
NovaBay Pharmaceuticals, Inc. (AMEX:NBY) Q3 2023 Earnings Call Transcript
|
Nov 10 |
NovaBay Pharmaceuticals, Inc. (NBY) Q3 2023 Earnings Call Transcript
|
Nov 9 |
NovaBay GAAP EPS of -$0.37 beats by $0.04, revenue of $3.27M misses by $0.27M
|
Nov 9 |
NovaBay Pharmaceuticals Reports Third Quarter 2023 Financial Results
|